Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Jun 04, 2019

SELL
$3.99 - $19.33 $970,946 - $4.7 Million
-243,345 Reduced 6.89%
3,290,079 $13.3 Million
Q1 2019

May 15, 2019

BUY
$3.99 - $19.33 $970,946 - $4.7 Million
243,345 Added 7.4%
3,533,424 $14.3 Million
Q2 2018

Aug 14, 2018

BUY
$19.83 - $24.17 $65.2 Million - $79.5 Million
3,290,079 New
3,290,079 $79.5 Million

About Aptinyx Inc.


  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.